Cognitive Impairment in New Cases of Epilepsy Randomly Assigned to Carbamazepine, Phenytoin and Sodium Valproate
The DOI matches its Crossref record.
Abstract
SUMMARY: Sixty‐four new cases of childhood epilepsy were randomly assigned to either carbamazepine, phenytoin or sodium valproate, and were assessed with cognitive tests before medication and three subsequent times over a year. Carbamazepine in moderate dosage adversely affected memory, but sodium valproate and phenytoin did not. RÉSUMÉ: Altérations cognitives dans les nouveaux cas d'épilepsie traités au hasard par la carbamazépine, la phénytoine et le valproate de sodium Soixante‐quatre nouveaux cas d'épilepsie de I'enfance ont été orientés au hasard vers un traitement par carbamazépine, phénytoine ou valproate de sodium et furent, évalués par des tests cognitifs avant le début de la médication et ultérieurement trois fois au cours d'une année. La carbamazépine à doses modérées altérait le mémoire, mais le valproate de sodium et la phénytoine ne le faisaient pas. ZUSAMMENFASSUNG: Kognifive Störungen bei neuen Epilepsiefällen, die wahllos mit Carbamazepin, Phenytoin oder Valproinsäure behandelt worden waren. 64 Neue Fälle mit kindlicher Epilepsie wurden willkürlich entweder mit Carbamazepin, Phenytoin oder Valproinsäure behandelt und vor der Therapie, sowie dreimal danach irn Verlauf eines Jahres, mit kognitiven Tests untersucht. Carbamazepin hatte in mäßiger Dosierung einen negativen Effekt auf das Gedächtnis, Valproinsäure und Phenytoin nicht. RESUMEN: Alteración cognitiva en casos nuevos de epilepsia tratados al azar con carbatnazepina, fenitoína y valproato sódico Sesenta y cuatro casos de epilepsia infantil fueron tratados al azar con carbamazepina, fenitoina y valproato sódico y fueron examinados con tests cognitivos antes de la medicación y tres veces más en el curso de un año. La carbamazepina a dosis moderadas afectaba adversamente a la memoria, cosa que no hacían ni el valproato ni la fenitoína.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Guerrini, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68182-8 · Cited by 848
Glauser, T., Ben‐Menachem, E., Bourgeois, B., Cnaan, A., Chadwick, D., Guerreiro, C., Kalviainen, R., Mattson, R., Perucca, E., & Tomson, T. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00585.x · Cited by 790
The cognitive impact of antiepileptic drugs
Eddy, C. M., Rickards, H. E., & Cavanna, A. E. (2011) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285611417920 · Cited by 404
Cognitive side effects of antiepileptic drugs
Ortinski, P., & Meador, K. J. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.11.008 · Cited by 316
Cognitive side effects of antiepileptic drugs in children
Loring, D. W., & Meador, K. J. (2004) · Neurology · doi:10.1212/01.wnl.0000115653.82763.07 · Cited by 265
Metadata
- Authors
- Forsythe, I., Butler, R., Berg, I., & McGuire, R.
- Venue
- Developmental Medicine & Child Neurology
- Publisher
- Wiley
- Published
- 1991-06
- Volume
- 33
- Issue
- 6
- Pages
- 524-534
- ISSN
- 0012-1622 (ISSN-L)
- 1469-8749
- OpenAlex
- W2168075369
- Cited by
- 129
- References
- 0
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cognitive Impairment in New Cases of Epilepsy Randomly Assigned to Carbamazepine, Phenytoin and Sodium Valproate. https://app.cochat.ai/papers/10.1111/j.1469-8749.1991.tb14917.x
- The paper
- Forsythe, I., Butler, R., Berg, I., & McGuire, R. (1991). Cognitive Impairment in New Cases of Epilepsy Randomly Assigned to Carbamazepine, Phenytoin and Sodium Valproate. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.1991.tb14917.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.